Tristan Orpin, Randy Armant, Richard Shippy, Sascha Drewlo
NIPT startup Cradle Genomics of San Diego announced its management team this week.
Tristan Orpin is the firm's CEO. Previously, he was chief commercial officer and executive VP of clinical genomics at Illumina. Prior to that, he held executive positions at Sequenom and at Bio-Rad Laboratories. Orpin has a BSc in genetics and biochemistry from the University of Melbourne.
Randy Armant is a cofounder and the firm's VP of research. He is a professor of obstetrics and gynecology at Wayne State University. Armant holds a PhD in developmental biology and biochemistry from Virginia Tech.
Richard Shippy is a cofounder and the company's VP of commercial. Previously, he was the senior director of strategic product marketing in reproductive and genetic health at Illumina. Before that, he held management positions in clinical market development at Affymetrix and at GE Healthcare. Shippy holds an MSc in biochemistry from Northern Illinois University.
Sascha Drewlo is a cofounder and Cradle's VP of development. He holds a PhD in molecular and cell biology from the German Sport University Cologne and an MSc in microbiology and genetics from the University of Münster.